Antiparkinsonian medication "Madopar": instructions for use

Medopar Medication Instructions for Usecharacterizes as a combined agent intended for the treatment of Parkinson's disease. Admission of this drug effectively removes muscle rigidity, hypokinesia and dysphagia. In addition, the medicine "Madopar" quickly copes with salivation and tremor. The pronounced effect from the use of this antiparkinsonian drug is noted six to eight days after the start of the admission, and the maximum result in twenty-five to thirty days. It should be especially noted that this medicine stimulates the evacuation of the stomach contents, which ultimately allows reaching its maximum concentration in the plasma in only three hours.

The combined product "Madopar"(instructions for use must be included) in the form of tablets, instant tablets and capsules. The latter have a hard gelatin structure and a pink-blue body.

Each capsule contains levodopa andBenserazide, acting as active components. Tablets "Madopar" are flat-cylindrical dragees of pale red color with a weak odor. They also contain substances such as levodopa and benserazide.

To write out the combined drug "Madopar"the instruction manual recommends mainly for the treatment of people suffering from Parkinson's disease. In addition, this tool is often prescribed for the purpose of eliminating restless legs syndrome. Finally, use this medication is recommended for people with kidney failure.

As for the main contraindications, thenprescribing tablets and capsules "Madopar" instruction for use strictly prohibits those patients who have serious heart disease, angle-closure glaucoma or mental disorders. In addition, doctors do not recommend the use of this antiparkinsonian drug in the case of decompensated liver, kidney or endocrine disruption. It is also strictly forbidden to prescribe this medicine to people under twenty-five years of age.

In case the patient has an allergicreaction to levodopa or benserazid, likewise, do not start taking Madopar tablets. Feedback, like the instruction, suggests the undesirability of prescribing this combination drug to people with bronchial asthma. With great care to take this anti-Parkinsonian remedy is necessary for patients with active peptic ulcer. Use the drug "Madopar" should not be in case of severe oppression of bone marrow hematopoiesis, melanoma, pregnancy or osteomalacia. The lactation period, arrhythmia and myocardial infarction are also included in the list of direct contraindications.

In addition to all of the above, we should sayand about the possible side effects and undesirable reactions that can be triggered by taking the Madopar tablets. So, for example, in the first days of treatment, loss of appetite, epigastric pain, dysphagia and vomiting are sometimes observed. There is also a small risk of developing orthostatic hypotension, thrombocytopenia, leukopenia, hemolytic anemia or tachycardia. In addition, some patients complain of depression, sleep disorders, insomnia, constipation and weight gain.